Page 4 - Opal Computational Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Valo Health to Participate in Financial Times US Pharma and Biotech Summit News provided by Share this article BOSTON, April 29, 2021 /PRNewswire/ --  Valo Health, LLC (Valo), the technology company that is using human-centric data, machine learning computation and life science expertise to transform and accelerate the drug discovery and development process, today announced that David Berry, Ph.D., founder and Chief Executive Officer of Valo will participate in a panel discussion during the Financial Times US Pharma and Biotech Summit on Wednesday, May 5, 2021 at 11:30 AM ET. The panel, " N...

Share Cedar, the maker of an intelligent patient billing and engagement platform, announced today a $200 million Series D round of funding headed by Tiger Global Management, with participation from prior backers including Andreessen Horowitz (a16z), Thrive Capital and Concord Health Partners. This brings the company's total fundraising haul to $350 million, it said, and its valuation to $3.2 billion. Cedar said that its patient-friendly digital offering has helped quadruple its business throughout the course of 2020 and now engages with more than 300,000 patients per day. It said it will...

Boston-based Valo Health LLC (Valo), a technology company working to transform the drug discovery and development process and accelerate the creation of life-changing drugs, closed a US$ 190 million Series B financing and unveiled select therapeutic programs. This is preferred equity capital. In total, Valo Health has raised over US$ 285 million. The financing was […]